Eli Lilly has announced a landmark trial demonstrating a major breakthrough with its Taltz-Zepbound drug combination for treating both psoriasis and obesity.

Lilly announced that a regimen including its drug Zepbound demonstrated success in a clinical trial for treating psoriasis.